METABOLIC DISORDERS
Bisphosphonates effective in osteoporotic males in terms of fracture, BMD, and biomarkers
Osteoporos Int. 2015 Sep;26(9):2355-63.9 randomized controlled trials, including 2464 patients, were included is this meta-analysis and systematic review, for the purpose of analyzing the efficacy of bisphosphonate therapy compared to placebo in males with osteoporosis. Results showed that bisphosphonates were effective in reducing the incidence of new vertebral and non-vertebral fractures, reducing serum bone turnover biomarkers, and in increasing lumbar spine, femoral neck, and total hip bone mineral density at up to 24 months follow-up.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
